Substances
Understanding Vivitrol Side Effects: Health Implications to Consider
Medically Reviewed By
Written By
Last medically reviewed March 10, 2025
Substances
Medically Reviewed By
Written By
Last medically reviewed March 10, 2025
Vivitrol, more commonly known as naltrexone, is the brand name for the medication that blocks the effects of opioids. When taking this medication as directed, users can reduce the risk of opioid abuse. However, it is also used to treat alcohol use disorder.
Vivitrol is an extended-release formulation of naltrexone, approved by the Food and Drug Administration (FDA) in 2010. To date, it is the only approved medication for opioid dependence.[1]
While this opioid receptor antagonist offers many advantages during addiction treatment, there are common side effects of Vivitrol. These side effects can cause potential health implications that all users and healthcare providers must remain mindful of. Understanding these potential side effects can help individuals weigh the advantages and risks more effectively to make more informed decisions.
This guide covers the possible health implications of taking Vivitrol — but also highlights how it is a beneficial addition to many treatment plans.
Before assessing the potential side effects of Vivitrol, you should consider the role it plays during addiction treatment. The FDA has approved it for both opioid use disorder (OUD) and alcohol use disorders (AUD). While you can get naltrexone in a pill form, Vivitrol is offered as an injectable.
This formulation is taken once monthly (compared to the pill form, which is taken daily). For many, that is a benefit, as taking one dose a month is easier, ensuring greater compliance. It’s more likely to skip a daily pill than a monthly injection — especially if you’re working closely with your healthcare team.
When you take Vivitrol, it blocks the effects of opioids and alcohol, eliminating the “feel good” effects of being high or drunk. Studies report that Vivitrol is successful at decreasing heavy drinking among alcohol-dependent users. Data shows that taking Vivitrol vs. a placebo led to fewer heavy drinking days (11.7% vs 25.3%, respectively).[2]
When studying opioid use disorder, Vivitrol has been shown to decrease opioid abuse. However, many who start Vivitrol discontinue treatment prematurely, which reduces its full clinical potential. This medication also appears to be most effective when users have already fully detoxed from opioids.[3]
Vivitrol is non-addictive, so it does not cause withdrawal symptoms following discontinued use. However, there are some safety precautions and the possibility of both common and serious side effects. Patients must discuss their options with healthcare practitioners, although most are good candidates — especially those suffering from opioid addiction (and are serious about overcoming this substance use disorder). In 2022, over 80,000 opioid overdose deaths were recorded in the United States.[4] Vivitrol helps protect against overdose, contributing to the fight against the opioid epidemic.
Some of the core advantages of Vivitrol include:
As reported by the FDA, adverse events do occur.
When treating alcohol dependence, ≥5% experience:[5]
When treating opioid use disorder, ≥2% experience:[5]
Certain side effects, like nausea, tend to improve within a few days after the first injection and become less likely with future injections. If you experience any abnormal Vivitrol shot side effects, you must tell your physician or care team immediately.
Discussing your customized treatment plan with your healthcare team is important, especially if you have a pre-existing condition.
In some cases, Vivitrol does cause serious side effects.
These adverse effects include:[5]
Some users will also have mild allergic reactions, which should be discussed with healthcare professionals to ensure continued use. Serious allergic reactions, such as swelling and trouble breathing, require emergency attention. There have also been rare case studies where reactions surface 10+ days after the initial injection.[6]
It is highly recommended that anyone taking Vivitrol communicate with family members and people that they are close to so that they know of the increased sensitivity to opioids and associated overdose risk.
When taking Vivitrol, although the medication does not cause an overdose directly, an accidental incident could occur. Since Vivitrol blocks the effects of opioids, some users may take excessive amounts of opioids when seeking a high. Unfortunately, coma or death can result. Those treated with Vivitrol also become more sensitive to opioids. If they relapse, they face a higher risk of an overdose.[7]
So, when there are complications, it is often when the next Vivitrol dose is due, when a dose of Vivitrol is missed, or when you discontinue treatment.
It is important to follow the recommended dose when administering Vivitrol, which is 380 mg, delivered intramuscularly every four weeks. A healthcare professional should administer this injection, as it must be given intramuscularly — not intravenously or subcutaneously (which is under the skin).
Individuals who are at risk of complications are those:[5]
It is recommended that you tell your healthcare provider if you:
Being aware of the possible serious side effects of Vivitrol is critical, so treatment centers often provide a Vivitrol medication guide. One important consideration is the last time you used the substances you’re being treated for. For example, if you plan on beginning Vivitrol treatment, you must be completely opioid-free. The recommended period is seven to 14 days before you start using Vivitrol, or else you could experience symptoms of opioid withdrawal.[8]
Sudden opioid withdrawal can be severe. Some individuals must go to the hospital, so honesty with your care team is important. The same process applies to alcohol — you should stop drinking alcohol before your first injection. For those who have a physical dependence on medications or street drugs, like heroin, you can ask for the naloxone challenge test. A small injection will be administered to see if you experience symptoms of withdrawal before a full dose is given.
The most common symptoms of opioid withdrawal include:[7]
Want to learn more about how to support yourself or a loved one? Contact the team at Southeast Detox in Georgia to learn more about medical detox support and our residential treatment programs today!
Long-term side effects of Vivitrol are rare but possible, particularly in at-risk individuals like those with liver disease. These effects may include liver injury and depression. For example, depression occurs in around 5% of users.[9] Symptoms may worsen while taking Vivitrol and continue without taking a more comprehensive approach. However, this relationship is complex, as addiction and mental health disorders are often linked. Each individual is unique and should seek a personalized treatment program.
Sublocade is another prescription medication used to treat those abusing opioids. The primary difference is that Sublocade’s active ingredient is buprenorphine, whereas Vivitrol contains naltrexone.[10]
While taking Vivitrol, you should avoid alcohol, opioids, and certain cannabis products (as they may cause drug interactions). If you are taking any medications or plan on starting new medications, please discuss them with your healthcare provider. By avoiding alcohol, you can decrease the risk of side effects like vomiting, dizziness, and tiredness. Also, until you know how Vivitrol affects you, it is best to avoid driving.[8] Arrange for someone to drive you on the day of your injection and then see how you react.
[1] UAMS. What is Vivitrol? Retrieved from https://psychiatry.uams.edu/research/center-for-addiction-research/what-is-vivitrol/ on 2024, Jan 10.
[2] Johnson BA. Naltrexone long-acting formulation in the treatment of alcohol dependence. Ther Clin Risk Manag. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2376083/ on 2024, Jan 10.
[3] Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow GE, Silverman K. Extended-release injectable naltrexone for opioid use disorder: a systematic review. Addiction. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5993595/ on 2024, Jan 10.
[4] Shulman M, Greiner MG, Tafessu HM, et al. Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Netw Open. Retrieved from https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2818410 on 2024, Jan 10.
[5] FDA. Highlights of Prescribing Information – Vivitrol. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021897s015lbl.pdf on 2024, Jan 10.
[6] Ahamad K, Korthuis PT, Lum PJ, Johnson C, Wood E. A delayed injection-site reaction in a patient receiving extended-release naltrexone. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5266530/ on 2024, Jan 10.
[7] SAMHSA. Naltrexone. Retrieved from https://www.samhsa.gov/substance-use/treatment/options/naltrexone on 2024, Jan 10.
[8] IHS. Vivitrol Treatment Consent and Agreement. Retrieved from https://www.ihs.gov/sites/opioids/themes/responsive2017/display_objects/documents/naltrexonetreatmentconsent.pdf on 2024, Jan 10
[9] Commonwealth of Massachusetts. AATOD Guidelines for Using Naltrexone (Vivitrol) in OTPs. Retrieved from https://www.mass.gov/doc/aatod-guidelines-for-using-naltrexone-1/download on 2024, Jan 10.
[10] Waddell EN, et al. Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). J Subst Abuse Treat. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8384640/ on 2024, Jan 10.